Klaudia Szałaj

Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia

Jens Carlsson, A. Kaczor, E. Fornal, 2023, Molecules.

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation

B. Budzyńska, A. Kaczor, E. Fornal, 2023, Journal of enzyme inhibition and medicinal chemistry.

LC–MS/MS-based quantification of tryptophan, kynurenine, and kynurenic acid in human placental, fetal membranes, and umbilical cord samples

W. Turski, E. Fornal, M. Deuschle, 2023, Scientific reports.